AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer

NCT00519233 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: AGS-1C4D4

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]